Research Analysts’ Weekly Ratings Updates for Guardant Health (GH)
Guardant Health (NASDAQ: GH) recently received a number of ratings updates from brokerages and research firms: 2/24/2026 – Guardant Health had its price target raised by Piper Sandler from $120.00 to $130.00. They now have an “overweight” rating on the stock. 2/23/2026 – Guardant Health had its “outperform” rating reaffirmed by Raymond James Financial, Inc.. […]
11 Mar 18:24 · The Markets Daily